Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes

Annals of Surgical Oncology

Volumn 11, Issue 7, 2004, Pages 658-664

  Uzan, Catherine ^a   Morice, Philippe ^a   Rey, Annie ^a   Pautier, Patricia ^a   Camatte, Sophie ^a   Lhommé, Catherine ^a   Haie Meder, Christine ^a   Duvillard, Pierre ^a   Castaigne, Damienne ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Lymphadenectomy; Nodal recurrence; Ovarian cancer; Prognosis

Indexed keywords

PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIMODALITY CANCER THERAPY; OVARY CARCINOMA; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR LOCALIZATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 16644388431     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.11.023     Document Type: Article

References (28)

1. Griffiths TC, Parker LM, Fuller AF. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 1979;63:235-40.
2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59.
3. Tsuruchi N, Kamura T, Tsukamoto N, et al. Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer-a multivariate analysis. Gynecol Oncol 1993;49:51-5.
4. Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and para-aortic lymphadenectomies and surgical implications. J Am Coll Surg 2003;197:198-205.
5. Benedetti-Panici PL, Landoni F, Scarabelli C, et al. An international randomized trial on systematic para-aortic and pelvic lymphadenectomy versus resection of any bulky nodes in advanced ovarian cancer. Preliminary results of feasibility and complications. 4th Conference on Ovarian Cancer. New York, September 11-13, 2003.
6. Janicke F, Holscher M, Kuhn W, et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 1992;70:2129-2136.
7. Segna RA, Dottino PR, Mandeli JP, Konsker K, Cohen CJ. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 1993;11:434-9.
8. Vaccarello L, Rubin SC, Vlamis V, et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 1995;57:61-5.
9. Gadducci A, Iacconi P, Cosio S, et al. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol 2000;79:344-9.
10. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000;88:144-53.
11. Scarabelli C, Gallo A, Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2001;83:504-12.
12. Munkarah A, Levenback C, Wolf JK, et al. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol 2001;81:237-41.
13. Tay EH, Grant PT, Gebski V, Hacker NF. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol 2002;99:1008-13.
14. Zang RY, Li ZT, Zang ZY, Cai SM. Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: A retrospective case-control study. Int J Gynecol Cancer 2003;13:419-27.
15. Bristow RE, del Carmen MG, Pannu HK, et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 2003;90:519-28.
16. Wu PC, Qu JY, Lang JH, Huang RL, Tang MY, Lian LJ. Lymph node metastasis from ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy. Am J Obstet Gynecol 1986;155:1103-8.
17. Di Re F, Fontanelli R, Raspagliesi F, Di Re E. Pelvic and paraaortic lymphadenectomy in cancer of the ovary. Baillieres Clin Obstet Gynaecol 1989;3:131-42.
18. Onda T, Yoshikawa H, Yokota H, Yasugi T, Taketani Y. Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy. Cancer 1996;78:803-8.
19. Petru E, Lahousen M, Tamussino K, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-62.
20. Tsumura N, Sakuragi N, Hareyama H, et al. Distribution pattern and risk factors for pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer 1998;23:526-30.
21. Onda T, Yoshikawa H, Yasugi T, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I/II patients and superior survival to other Stage m patients. Cancer 1998;83:1555-60.
22. Burghardt E, Winter R. The effect of chemotherapy on lymph node metastases in ovarian cancer. Baillieres Clin Obstet Gynaecol 1989;3:167-71.
23. Wu PC, Eang JH, Huang RL, et al. Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer. Baillieres Clin Obstet Gynaecol 1989;3:143-55.
24. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol 1995;56:328-37.
25. Baiocchi G, Grosso G, Di Re E, Fontanelli R, Raspagliesi F, Di Re F. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer. Gynecol Oncol 1998;69:151-6.
26. Zinzindohoue C, Lujan R, Boulet S, Spirito C, Bobin JY. Pelvic and para-aortic lymphadenectomy in epithelial ovarian cancer. Report of a series of 86 cases. Ann Chir 2000;125:163-72.
27. Morice P, Joulie F, Rey A, et al. Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy. Eur J Gynaecol Oncol 2004;25:169-74.
28. Kuhn W, Schmalfeldt B, Fache L, et al. Disease-adapted relapse therapy for ovarian cancer: results of a prospective study. Int J Oncol 1998;13:57-63.